These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 34331416)

  • 21. Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.
    Bennett SE; Walsh N; Moss T; Palmer S
    Disabil Rehabil; 2022 Sep; 44(18):5231-5240. PubMed ID: 34101520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of pain with gait spatiotemporal parameters in children with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder.
    Jeong HJ; Engel JM; Muriello M; Basel D; Slavens BA
    Gait Posture; 2024 Mar; 109():271-276. PubMed ID: 38368648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of five isometric exercises on glenohumeral translations in healthy subjects and patients with the hypermobility type of the ehlers-danlos syndrome (heds) or hypermobility spectrum disorder (hsd) with multidirectional shoulder instability: an observational study.
    Spanhove V; De Wandele I; Kjær BH; Malfait F; Vanderstukken F; Cools A
    Physiotherapy; 2020 Jun; 107():11-18. PubMed ID: 32026810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of gastrointestinal function and its' effect on bone mineral density and body composition in hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome.
    DiFrancisco-Donoghue J; Southard V; Margulies M; Jung MK; Allera A; Riley B
    J Clin Densitom; 2022; 25(4):536-543. PubMed ID: 35945116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of childbearing with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: A scoping review and expert co-creation of evidence-based clinical guidelines.
    Pezaro S; Brock I; Buckley M; Callaway S; Demirdas S; Hakim A; Harris C; High Gross C; Karanfil M; Le Ray I; McGillis L; Nasar B; Russo M; Ryan L; Blagowidow N
    PLoS One; 2024; 19(5):e0302401. PubMed ID: 38748660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The concomitant diagnosis of fibromyalgia and connective tissue disorders: A systematic review.
    Alsiri N; Alhadhoud M; Alkatefi T; Palmer S
    Semin Arthritis Rheum; 2023 Feb; 58():152127. PubMed ID: 36462303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS).
    Kucharik AH; Chang C
    Clin Rev Allergy Immunol; 2020 Jun; 58(3):273-297. PubMed ID: 31267471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of hypermobile Ehlers-Danlos syndrome in postural orthostatic tachycardia syndrome.
    Miller AJ; Stiles LE; Sheehan T; Bascom R; Levy HP; Francomano CA; Arnold AC
    Auton Neurosci; 2020 Mar; 224():102637. PubMed ID: 31954224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Spider: a visual, multisystemic symptom impact questionnaire for people with hypermobility-related disorders-validation in adults.
    Ewer ER; De Pauw R; Kazkazk H; Ninis N; Rowe P; Simmonds JV; De Wandele I
    Clin Rheumatol; 2024 Sep; 43(9):3005-3017. PubMed ID: 39085705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomised controlled trial of heavy shoulder strengthening exercise in patients with hypermobility spectrum disorder or hypermobile Ehlers-Danlos syndrome and long-lasting shoulder complaints: study protocol for the Shoulder-MOBILEX study.
    Liaghat B; Skou ST; Søndergaard J; Boyle E; Søgaard K; Juul-Kristensen B
    Trials; 2020 Dec; 21(1):992. PubMed ID: 33261635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use and effectiveness of exercise for managing postural orthostatic tachycardia syndrome in young adults with joint hypermobility and related conditions: A scoping review.
    Peebles KC; Jacobs C; Makaroff L; Pacey V
    Auton Neurosci; 2024 Apr; 252():103156. PubMed ID: 38401460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical and mechanical therapies for lower limb symptoms in children with Hypermobility Spectrum Disorder and Hypermobile Ehlers-Danlos Syndrome: a systematic review.
    Peterson B; Coda A; Pacey V; Hawke F
    J Foot Ankle Res; 2018; 11():59. PubMed ID: 30455744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Zoppi N; Chiarelli N; Binetti S; Ritelli M; Colombi M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1010-1023. PubMed ID: 29309923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone parameters in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder: A comparative cross-sectional study.
    Coussens M; Banica T; Lapauw B; De Wandele I; Rombaut L; Malfait F; Calders P
    Bone; 2023 Jan; 166():116583. PubMed ID: 36243401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history of aortic root dilation through young adulthood in a hypermobile Ehlers-Danlos syndrome cohort.
    Ritter A; Atzinger C; Hays B; James J; Shikany A; Neilson D; Martin L; Weaver KN
    Am J Med Genet A; 2017 Jun; 173(6):1467-1472. PubMed ID: 28436618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An exploratory study of clinical characteristics and gait features of adolescents with hypermobility disorders.
    de Koning LE; Scheper MC; Ploeger HE; Warnink-Kavelaars J; Oosterlaan J; Bus SA; Engelbert RHH
    Gait Posture; 2023 Feb; 100():222-229. PubMed ID: 36638668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding hypermobile Ehlers-Danlos syndrome and Hypermobility Spectrum Disorders in the context of childbearing: An international qualitative study.
    Pezaro DS; Pearce DG; Reinhold DE
    Midwifery; 2020 Sep; 88():102749. PubMed ID: 32535291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center.
    Ritelli M; Chiarelli N; Cinquina V; Vezzoli M; Venturini M; Colombi M
    Am J Med Genet A; 2024 Feb; 194(2):174-194. PubMed ID: 37774134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorder.
    Brock I; Prendergast W; Maitland A
    Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):473-481. PubMed ID: 34747107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postural tachycardia syndrome and other forms of orthostatic intolerance in Ehlers-Danlos syndrome.
    Roma M; Marden CL; De Wandele I; Francomano CA; Rowe PC
    Auton Neurosci; 2018 Dec; 215():89-96. PubMed ID: 29519641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.